Mouchawar et al. examined early-onset breast cancer patients and found that three of five TP53 mutation carriers did not meet the classic LFS or LFL (Li-Fraumeni-like) syndrome criteria [7]. Here, TP53 is linked to Li-fraumeni-like syndrome.